Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
267
267 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- celiprololACER-002Phase 31 trial
Acer Therapeutics Inc. · Vascular Ehlers-Danlos Syndrome
- GB06Phase 31 trial
Kexing Biopharm Co., Ltd. · Growth Hormone Deficiency (GHD), Growth Hormone Deficiency in Children, Growth Hormone Deficiency, Pediatric
- GC5107GCC 10% IGIVPhase 31 trial
GC Biopharma Corp · Primary Immune Deficiency
- GNR-055GNR-055 1.0-2.0Phase 31 trial
AO GENERIUM · Mucopolysaccharidosis Type II, Metabolic Diseases
- IgPro20Immune Globulin 20% LiquidPhase 31 trial
CSL Behring · Secondary Immune Deficiency
- KK8398Phase 31 trial
Kyowa Kirin Co., Ltd. · Achondroplasia
- KP-001Phase 31 trial
Kaken Pharmaceutical · Venous Malformations, Lymphatic Malformations, Klippel-Trenaunay Syndrome
- NTLA-2002Phase 31 trial
Intellia Therapeutics · Hereditary Angioedema
- NVD003Phase 31 trial
Novadip Biosciences · Congenital Pseudarthrosis of Tibia
- NXC-201Phase 31 trial
Nexcella Inc. · Light Chain (AL) Amyloidosis
- PJ009Phase 31 trial
Chongqing Peg-Bio Biopharm Co., Ltd. · Short Bowel Syndrome
- RilogrotugPhase 31 trial
AVEO Pharmaceuticals, Inc. · Cachexia; Cancer, Cachexia, Cachexia-Anorexia Syndrome
- RT001Deuterated linoleic acidPhase 31 trial
Biojiva LLC · Infantile Neuroaxonal Dystrophy
- rugonersenPhase 31 trial
OHB Pediatrics Ltd. · Angelman Syndrome
- SRP-9003Phase 31 trial
Sarepta Therapeutics, Inc. · Limb-girdle Muscular Dystrophy
- THRV-1268Phase 31 trial
Thryv Therapeutics · Long QT Syndrome (LQTS) 2
- NM8074Phase 28 trials
NovelMed Therapeutics · Paroxysmal Nocturnal Hemoglobinuria, Dermatomyositis, PNH - Paroxysmal Nocturnal Hemoglobinuria
- UC-MSCRY_SW01 cell, Human umbilical cord mesenchymal stem cellsPhase 28 trials
Jiangsu Renocell Biotech Company · Acute Respiratory Distress Syndrome, Lupus Nephritis, Spinocerebellar Ataxia Type 1
- AtibuclimabIC14Phase 24 trials
Implicit Bioscience · Acute Respiratory Distress Syndrome, Adult Respiratory Distress Syndrome, Acute Lung Injury
- DabogratinibTYRA-300Phase 24 trials
Tyra Biosciences, Inc · FGFR3 Gene Mutation, FGFR3 Gene Alteration, Achondroplasia
- Descartes-08Phase 24 trials
Cartesian Therapeutics · Myasthenia Gravis, Generalized, Childhood-onset Systemic Lupus Erythematous, ANCA-Associated Vasculitis (AAV)
- MAS825ArumakimigPhase 24 trials
Novartis · NLRC4-GOF, AIFEC (Autoinflammation With Infantile Enterocolitis), XIAP Deficiency, CDC42 Mutations, Still´s Disease, VEXAS Syndrome
- RimonabantPhase 24 trials
Sinfatin S.L · Chronic Stroke, Subacute Stroke, Post-COVID-19 Syndrome
- SecretomeConditioned, Umbilical Cord Mesenchymal Stem Cells derived ConditionedPhase 24 trials
PT. Prodia Stem Cell Indonesia · Acute Respiratory Distress Syndrome, Androgenetic Alopecia, Ischemic Stroke
- SevasemtenPhase 24 trials
Edgewise Therapeutics, Inc. · Becker Muscular Dystrophy, Duchenne Muscular Dystrophy
- AP1189Phase 23 trials
SynAct Pharma Aps · Rheumatoid Arthritis (RA), Nephrotic Syndrome Due to Idiopathic Membranous Nephropathy, Severe Proteinuria Due to Idiopathic Membranous Nephropathy
- BrogidirsenNS-089, NCNP-02Phase 23 trials
NS Pharma, Inc. · Duchenne Muscular Dystrophy, Exon 44, DMD
- ESG206ESG206-2Phase 23 trials
Shanghai Escugen Biotechnology Co., Ltd · Systemic Lupus Erythematosus (SLE), Immune Thrombocytopenia (ITP), Primary Sjögren Syndrome
- ETX101Phase 23 trials
Encoded Therapeutics · Dravet Syndrome
- Lu AG13909AsedebartPhase 23 trials
H. Lundbeck A/S · Cushing's Disease, Congenital Adrenal Hyperplasia, Adrenal Hyperplasia, Congenital
- RimiducidAP1903Phase 23 trials
Bellicum Pharmaceuticals · Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, Leukemia, Acute Myeloid (AML), Child
- RVU120SEL120Phase 23 trials
Ryvu Therapeutics SA · Advanced Solid Tumors, Acute Myeloid Leukaemia (AML), High-risk Myelodysplastic Syndrome
- SPI-62clofutriben, ASP3662Phase 23 trials
Sparrow Pharmaceuticals · Cortisol Excess, Type 2 Diabetes, Polymyalgia Rheumatica
- 4D-310Phase 22 trials
4D Molecular Therapeutics · Fabry Disease
- ABSK061Phase 22 trials
Abbisko Therapeutics Co, Ltd · HER2-Gastric/Gastroesophageal Junction Cancer, Urothelial Carcinoma, Non-Small Cell Lung Cancer
- ALN-6400Phase 22 trials
Alnylam Pharmaceuticals · Von Willebrand Disease (VWD), Heavy Menstrual Bleeding (HMB), Hereditary Hemorrhagic Telangiectasia
- bexmarilimabFP-1305Phase 22 trials
Faron Pharmaceuticals Ltd · Higher Risk Myelodysplastic Syndromes, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia
- BLEX 404 LiquidPhase 22 trials
BioLite, Inc. · Myelodysplastic Syndrome (MDS), Triple Negative Breast Cancer
- BMB-101Phase 22 trials
Bright Minds Biosciences Pty Ltd · Absence Epilepsy, Jeavons Syndrome, Dravet Syndrome
- BMN 351Phase 22 trials
BioMarin · Duchenne Muscular Dystrophy (DMD), Duchenne Muscular Dystrophy
- DibotatugDR-01Phase 22 trials
Dren Bio · Bone Marrow Failure Syndromes, Aplastic Anemias, Severe Aplastic Anemia (SAA)
- DISC-0974Phase 22 trials
Disc Medicine, Inc · Anemia, Inflammatory Bowel Disease (IBD), Inflammatory Bowel Disease (IBD); Anemia
- ENTR-601-44Phase 22 trials
Entrada Therapeutics, Inc. · Duchenne Muscular Dystrophy (DMD)
- ENTR-601-45Phase 22 trials
Entrada Therapeutics, Inc. · Duchenne Muscular Dystrophy (DMD)
- FKC289Phase 22 trials
Shenzhen Fosun Kairos Biotechnology Co., Ltd. · Primary Membranous Nephropathy, Primary Light Chain (AL) Amyloidosis
- GenSci134Phase 22 trials
Changchun GeneScience Pharmaceutical Co., Ltd. · Pediatric Growth Hormone Deficiency, Idiopathic Short Stature
- Intravitreal of UltevursenPhase 22 trials
Laboratoires Thea · Retinitis Pigmentosa (RP), Usher Syndrome Type 2, Deaf Blind
- JR-446Phase 22 trials
JCR Pharmaceuticals Co., Ltd. · Mucopolysaccharidosis III-B, Mucopolysaccharidosis IIIB
- mivelsiranALN-APPPhase 22 trials
Alnylam Pharmaceuticals · Cerebral Amyloid Angiopathy, Down Syndrome-Associated Alzheimer's Disease (DS-AD)
- OfirnoflastHT-6184Phase 22 trials
Halia Therapeutics, Inc. · Myelodysplastic Syndromes, Anemia, Myelodysplastic Syndrome
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.